The B2B pricing strategy framework we install for every client for healthcare and life sciences in North America

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in North America. In this market, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed, so the way you install B2B pricing strategy has to be shaped to that reality from day one.

We have installed B2B pricing strategy inside more than fifty companies. This is the framework we reach for every time. B2B pricing strategy is the deliberate choice of unit, level, and packaging that maximises expansion revenue, and the framework exists to keep that definition honest under real conditions.

Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. B2B pricing strategy applied to the wrong constraint is theatre.

Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in North America it is compounded by the fact that signal above noise, not lead volume is what actually gates growth. B2B pricing strategy is only useful here when it is pointed at both constraints at once.

Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.

Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.

Part five, operating rhythm. Monday plan, Friday review, weekly net revenue retention. Nothing about the model is left to memory.

Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, B2B pricing strategy compounds and the framework stops being visible.

Concretely for healthcare and life sciences in North America: the healthcare teams that install this get past procurement instead of dying in it, and the North American teams that install this land inside the first quarter, not the fourth. That is the reason it is worth installing B2B pricing strategy deliberately for this market rather than importing a playbook designed for somewhere else.